Shannon Campbell
Vermögen: 16 711 $ am 30.09.2026
Vermögen: 16 711 $ am 30.09.2026
Ms. Shannon Campbell is an Independent Director at Black Diamond Therapeutics, Inc. She is on the Board of Directors at Hansa Biopharma AB, Zentalis Pharmaceuticals, Inc. and Black Diamond Therapeutics, Inc. Ms. Campbell was previously employed as a Chief Commercial Officer & Executive VP by Merus NV and a Vice President & General Manager-Oncology by Bayer HealthCare Pharmaceuticals, Inc. She received her undergraduate degree from Ithaca College.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 26.06.2026 | 8.865 ( 0,02 % ) | 16 711 $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 10.04.2024 |
| ZENTALIS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 22.05.2026 |
| HANSA BIOPHARMA AB | Direktor/Vorstandsmitglied | 22.09.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
| MERUS N.V. | Corporate Officer/Principal | 01.01.2026 |
Bayer HealthCare Pharmaceuticals, Inc.
Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drugs | Corporate Officer/Principal | 01.01.2017 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Ithaca College
Ithaca College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer HealthCare Pharmaceuticals, Inc.
Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drugs | Health Technology |
Merus NV
Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Hansa Biopharma AB
Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory | Health Technology |
Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops precision medicines for cancer | Health Technology |
Zentalis Pharmaceuticals, Inc.
Zentalis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops clinical therapeutics for targeting fundamental cancer pathways | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen